General Information of the Compound
Compound ID
CP0018887
Compound Name
5-[5-(benzylamino)-1,3,4-oxadiazol-2-yl]-1,3-dihydroindol-2-one
    Show/Hide
Structure
Formula
C17H14N4O2
Molecular Weight
306.325
Canonical SMILES
O=C1Cc2cc(ccc2N1)-c1nnc(NCc2ccccc2)o1
    Show/Hide
InChI
InChI=1S/C17H14N4O2/c22-15-9-13-8-12(6-7-14(13)19-15)16-20-21-17(23-16)18-10-11-4-2-1-3-5-11/h1-8H,9-10H2,(H,18,21)(H,19,22)
    Show/Hide
InChIKey
WOYFMTIGVCKOTG-UHFFFAOYSA-N
Physicochemical Property
logP
2.8433
Rotatable Bonds
4
Heavy Atom Count
23
Polar Areas
80.05
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 72547519
ChEMBL ID
CHEMBL3093061
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00985, Cell division cycle 7-related protein kinase
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000067 HCT 116 Homo sapiens (Human)  1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS